Electromed Inc is a United States-based company that develops, manufactures and markets airway clearance products that apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of all ages. The company markets its products in the U.S. to the homecare and hospital markets. Its product includes the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The company operates in a single segment: developing, manufacturing, and marketing medical equipment. Tghe company generates revenue from Homecare, Hospital, Homecare Distributor, and Other.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 5 | 21,501 | $783K |
| Option exercise | 6 | 38,602 | |
| Tax withholding / forfeiture | 1 | 674 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
25 Form 4 filings on record, the earliest from Oct 2, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Bradley M. Nagel - Officer | Tax withholding / forfeiture | Common Stock | 674 | $42.30 | $29K | |
| Option exercise | Common Stock | 9,700 | $17.25 | $167K | ||
| Open-market sale | Common Stock | 7,003 | $36.25 | $254K | ||
| Open-market sale | Common Stock | 1,671 | $36.80 | $61K | ||
| Open-market sale | Common Stock | 1,026 | $37.77 | $39K | ||
| Option exercise | Employee Stock Option (right to buy) | 9,700 | $0.00 | - | ||
| Bradley M. Nagel - Officer | Option exercise | Common Stock | 4,334 | $10.25 | $44K | |
| Bradley M. Nagel - Officer | Option exercise | Common Stock | 5,267 | $10.71 | $56K | |
| Bradley M. Nagel - Officer | Open-market sale | Common Stock | 11,620 | $36.34 | $422K | |
| Bradley M. Nagel - Officer | Open-market sale | Common Stock | 181 | $37.11 | $7K | |
| Bradley M. Nagel - Officer | Option exercise | Employee Stock Option (right to buy) | 4,334 | $0.00 | - | |
| Bradley M. Nagel - Officer | Option exercise | Employee Stock Option (right to buy) | 5,267 | $0.00 | - | |
| Option exercise | Common Stock | 40,000 | $3.82 | $153K | ||
| Open-market sale | Common Stock | 3,562 | $37.33 | $133K | ||
| Open-market sale | Common Stock | 8,150 | $34.36 | $280K | ||
| Open-market sale | Common Stock | 19,032 | $35.24 | $671K | ||
| Open-market sale | Common Stock | 9,256 | $36.26 | $336K | ||
| Option exercise | Employee Stock Option (right to buy) | 40,000 | $0.00 | - | ||
| Grant or award | Common Stock | 3,000 | $0.00 | - | ||
| Grant or award | Common Stock | 3,000 | $0.00 | - | ||
| Gregory Fluet - Director | Grant or award | Common Stock | 3,000 | $0.00 | - | |
| Kathleen A. Tune - Director | Grant or award | Common Stock | 3,000 | $0.00 | - | |
| Stan K. Erickson - Director | Grant or award | Common Stock | 3,000 | $0.00 | - | |
| Joseph L. Galatowitsch - Director | Grant or award | Common Stock | 3,000 | $0.00 | - | |
| Andrea M. Walsh - Director | Grant or award | Common Stock | 3,000 | $0.00 | - | |
| Open-market sale | Common Stock | 39,378 | $23.68 | $932K | ||
| Open-market sale | Common Stock | 16,203 | $25.16 | $408K | ||
| Open-market sale | Common Stock | 6,576 | $25.94 | $171K | ||
| Open-market sale | Common Stock | 404 | $26.62 | $11K | ||
| Open-market sale | Common Stock | 3,153 | $24.42 | $77K | ||
| Bradley M. Nagel - Officer | Tax withholding / forfeiture | Common Stock | 562 | $23.95 | $13K | |
| Bradley M. Nagel - Officer | Grant or award | Common Stock | 5,300 | $0.00 | - | |
| Bradley M. Nagel - Officer | Grant or award | Employee Stock Option (right to buy) | 9,800 | $0.00 | - | |
| Tax withholding / forfeiture | Common Stock | 1,291 | $23.95 | $31K | ||
| Grant or award | Common Stock | 17,000 | $0.00 | - | ||
| Grant or award | Employee Stock Option (right to buy) | 31,100 | $0.00 | - | ||
| Open-market sale | Common Stock | 17,159 | $28.09 | $482K | ||
| Open-market sale | Common Stock | 1,157 | $28.89 | $33K | ||
| Open-market sale | Common Stock | 160 | $29.41 | $5K | ||
| Open-market sale | Common Stock | 17,597 | $28.09 | $494K | ||
| Open-market sale | Common Stock | 1,169 | $28.81 | $34K | ||
| Open-market sale | Common Stock | 162 | $29.40 | $5K | ||
| Open-market sale | Common Stock | 8,370 | $29.97 | $251K | ||
| Open-market sale | Common Stock | 362 | $30.80 | $11K | ||
| Open-market sale | Common Stock | 8,731 | $30.18 | $264K | ||
| Open-market sale | Common Stock | 17,718 | $30.21 | $535K | ||
| Open-market sale | Common Stock | 17,718 | $30.15 | $534K | ||
| Open-market sale | Common Stock | 6,366 | $30.10 | $192K | ||
| Open-market sale | Common Stock | 6,365 | $29.86 | $190K | ||
| Joseph L. Galatowitsch - Director | Grant or award | Common Stock | 3,000 | $0.00 | - | |
| Stan K. Erickson - Director | Grant or award | Common Stock | 3,000 | $0.00 | - | |
| Grant or award | Common Stock | 3,000 | $0.00 | - | ||
| Grant or award | Common Stock | 3,000 | $0.00 | - | ||
| Gregory Fluet - Director | Grant or award | Common Stock | 3,000 | $0.00 | - | |
| Kathleen A. Tune - Director | Grant or award | Common Stock | 3,000 | $0.00 | - | |
| Andrea M. Walsh - Director | Grant or award | Common Stock | 3,000 | $0.00 | - | |
| Open-market sale | Common Stock | 42,453 | $28.16 | $1.20M | ||
| Open-market sale | Common Stock | 50,602 | $27.92 | $1.41M | ||
| Open-market sale | Common Stock | 56,945 | $27.97 | $1.59M | ||
| Option exercise | Common Stock | 87,500 | $0.00 | - | ||
| Tax withholding / forfeiture | Common Stock | 34,426 | $21.47 | $739K | ||
| Option exercise | Performance Stock Units | 87,500 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
Electromed, Inc. (ELMD) had 3 insider filings in the last 90 days, with the most recent on 2026-07-02. The full record for ELMD runs to 25 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of ELMD were filed in the last 90 days.
5 insider sales of ELMD were filed in the last 90 days, totaling $783K.
This page tracks ELMD Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add ELMD to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.